Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism
暂无分享,去创建一个
M. López-Guerra | M. Rozman | J. Yagüe | Núria Bonet | Ò. Fornas | M. Fernández-Figueras | E. Vicente-Rabaneda | R. Sanmartí | G. Magri | J. Aróstegui | L. Caminal-Montero | M. Cid | E. González-Roca | S. Buján | I. Rodríguez-Pintó | S. Plaza | M. Andrés | N. Quilis | G. Espigol-Frigolé | V. Fabregat | F. Casals | R. Gómez de la Torre | P. Fanlo | R. Coto-Hernández | I. Figueras | A. Mensa‐Vilaró | J. Hernández-Rodríguez | Alba Alvarez-Abella | Manuel Solis-Moruno | J. I. Elejalde | Sonia Tejedor-Vaquero | J. Mascaró | Gabriela Poza | J. Fernandez-Martin | Gerard Espinosa | Marina Diaz | Joana Rita-Marques | Raimon Sanmarti | Santos Castañeda | D. Colunga | Francisco Manuel Marco | M. Andrés | Silvia Suárez | Andres Gonzalez-Garcia | Xavier Fustà-Novell | C. Garcia-Belando | Ana Granados | Maria Orriols-Caba | Eztizen Labrador | Paola Castillo | Jose R Alamo-Moreno | Rocio Lara | Andrea Cerutti | Alba Álvarez-Abella | Santos Castañeda | S. Suárez | Andres González-García
[1] D. Kastner,et al. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population. , 2023, JAMA.
[2] V. Bigley,et al. Allogeneic haematopoietic stem cell transplantation for VEXAS syndrome: UK experience , 2022, British journal of haematology.
[3] N. Young,et al. VEXAS syndrome , 2022, International Journal of Hematology.
[4] T. Cluzeau,et al. Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report , 2022, Bone Marrow Transplantation.
[5] K. Götze,et al. Successful treatment with azacitidine in VEXAS syndrome with prominent myofasciitis. , 2021, Rheumatology.
[6] B. Quesnel,et al. Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience , 2021, Blood advances.
[7] J. Yagüe,et al. First Description of Late‐Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism , 2021, Arthritis & rheumatology.
[8] P. Fenaux,et al. Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registry , 2021, British journal of haematology.
[9] F. Carrat,et al. Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients * , 2021, The British journal of dermatology.
[10] E. Clappier,et al. UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS Syndrome. , 2021, JAMA dermatology.
[11] J. Rossignol,et al. Atypical splice site mutations causing VEXAS syndrome. , 2021, Rheumatology.
[12] I. Aksentijevich,et al. Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases , 2021, Nature Reviews Rheumatology.
[13] A. Hoischen,et al. Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of VEXAS patients. , 2021, The Journal of allergy and clinical immunology.
[14] P. Evans,et al. Novel somatic mutations in UBA1 as a cause of VEXAS syndrome , 2021, Blood.
[15] J. Mullikin,et al. Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. , 2020, The New England journal of medicine.
[16] C. Calabrese,et al. Somatic mosaicism in adult‐onset TNF receptor‐associated periodic syndrome (TRAPS) , 2019, Molecular genetics & genomic medicine.
[17] D. Steensma. Clinical consequences of clonal hematopoiesis of indeterminate potential. , 2018, Blood advances.
[18] P. Hawkins,et al. Late-Onset Cryopyrin-Associated Periodic Syndromes Caused by Somatic NLRP3 Mosaicism—UK Single Center Experience , 2017, Front. Immunol..
[19] J. Yagüe,et al. Brief Report: Late‐Onset Cryopyrin‐Associated Periodic Syndrome Due to Myeloid‐Restricted Somatic NLRP3 Mosaicism , 2016, Arthritis & rheumatology.
[20] Gabor T. Marth,et al. A global reference for human genetic variation , 2015, Nature.
[21] E. Remmers,et al. Cryopyrin-associated Periodic Syndrome Caused by a Myeloid-Restricted Somatic NLRP3 Mutation , 2015 .
[22] B. Ebert,et al. Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.
[23] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[24] B. Turner. Hospital , 2006 .
[25] R. Joynt. Department , 1960, Neurology.
[26] J. Yagüe,et al. Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases , 2019, The Journal of allergy and clinical immunology.